|Articles|April 14, 2021
- Pharmaceutical Executive-04-01-2021
- Volume 41
- Issue 4
Pharmaceutical Executive, April 2021 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive April 2021 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 5 years ago
The Challenges of Worker Qualification Management in Pharmaabout 5 years ago
The Future of Telehealth: Evolving COVID Perspectives Offer Cluesabout 5 years ago
Years in the Making: A Repeat Recognition—Uninterruptedabout 5 years ago
Pharm Exec at 40 (1990-1993)about 5 years ago
The Power of Parityabout 5 years ago
No Limits to Science, Or Selfabout 5 years ago
In Silico in Sight as Biopharma Game-Changerabout 5 years ago
Long-View Innovation Hopes for Pharma Policy in the EUAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Beyond JAK Inhibitors: Biologics Signal a New Era in Alopecia Areata
2
Pharma M&A Roundup: Incyte to Acquire Vega Therapeutics, Galmed Pharmaceuticals to Acquire Colospan, Johnson & Johnson Acquires Firefly Bio
3
Chai Discovery Enters License Agreement with Pfizer to Accelerate Drug Discovery with AI
4
U.S. Supreme Court Unanimously Votes in Favor of Hikma in Case Against Amarin: Report
5